Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus dexmedetomidine for prevention of agitation during pediatric bone marrow procedures
IRCT20240416061503N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cancer comparing Ketamine with Dexmedetomidine (2 arms). Primary endpoints: 4-point sedation scale at 30 minutes, Respiratory rate at 30 minutes and 3 more. Started Apr 2024; status: completed.
02
Drugs
ketaminedexmedetomidine
03
Conditions
cancer
Beyond the preview
Go deeper on IRCT20240416061503N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240416061503N1.